Jin Medical International Ltd. (ZJYL) is a leading manufacturer of wheelchairs and living aids in China, serving domestic and international markets (primarily Japan). The company recently completed a 1-for-20 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. While the company faces declining year-over-year revenues and compressed profit margins, its strategic expansion into the Chuzhou facility—which achieved final construction milestones and Class I medical device licensing—is expected to significantly scale up production of high-margin electric wheelchairs and mobility scooters. Given the operational transition and high stock volatility, a neutral view is warranted until the new capacity translates into stabilized revenue growth and improved profitability.